OUR WINNING WAYS

Zylö Therapeutics

• 2023: Finalist of InnoVision’s 2023 competition for top technology applications in South Carolina—winner to be announced in October 2023. (InnoVision Awards is South Carolina’s premier organization dedicated to the advancement of innovation and technology. The awards are the mark of distinction for outstanding leadership, innovation, and technological excellence.)

• 2023: Winner of Pitch Contest at SCBIO’s Annual Conference in Charleston SC

• 2022: Winner of InnoVision's 2022 award for top technology company in South Carolina.

Andrew Draganski, Ph.D., Zylö's Head of Product Development and Co-Scientific Founder of Zylö

• 2023: $300,000 Phase 1 SBIR grant titled "Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus” was awarded by the NIH, with A. Draganski  Ph.D. and V. Werth M.D. as  co-PIs [read publication].

• 2022: $260,000 Phase 1 SBIR grant titled "Optimization of a nanoparticle-based topical PDE5i formulation for treatment of erectile dysfunction" was awarded by the NIH, with A. Draganski as the PI.

• 2022: $600,000 Phase 1 SBIR grant titled "Development and optimization of a nitric oxide releasing microparticle-based topical treatment for onychomycosis" was awarded by the NIH, with A. Draganski as the PI.

• 2021: $1,700,000 Phase 2 SBiR grant titled "Development of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors" was awarded by the NIH, with A. Draganski as the PI.

• 2021:  $700,000 Phase 1 grant titled “Injectable Antimicrobial Hydrogel for Extremity Wound Management” was awarded by the DoD, with J. Taboas Ph.D. (U. of Pittsburgh) as PI and A. Draganski as a key contributor.

• 2021: Best Abstract  (Basic Science category) was awarded at the annual scientific meeting of the North American Sexual Medicine Society of North America (SMSNA), held October 21-24, 2021., The abstract, titled “Synergy Between Sildenafil and Topically Delivered Nitric-Oxide in Eliciting an Erectile Response in a Rat Model of Radical Prostatectomy” was presented by Moses Tar M.D. of Albert Einstein College of Medicine and was co-authored by A. Draganski and K. Davies, professor of urology and professor of physiology and biophysics at Einstein College.

• 2019: $225,000 Phase 1 STTR grant titled "Optimization of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors" was awarded by the NIH. A. Draganski and K. Davies were co-PIs.

• 2017: Top prize, with co-authors M Tar, G Villegas, J Friedman, K Davies, for Best Male Sexual Health Essay at the 18th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America in October 2017 (San Antonio):  ”Topical Abdominal Application of Curcumin-Loaded Nanoparticles Protects Erectile Function in a Rat Model of Type 2 Diabetes” 

• 2017: Pfizer & Sexual Medicine Society of North America Research Grant Award for his project: "Anti-inflammatory curcumin-releasing nanoparticles to treat erectile dysfunction"

Joel Friedman, M.D., Ph.D., Co-Scientific Founder of Zylö

• A collaborative team effort led by Waleed Abuzeid MD, Assistant Professor at Montefiore Hospital, and Joel Friedman MD PhD, Professor at Einstein College of Medicine, yielded early success in a promising new approach for chronic rhino sinusitis using Zylö’s Z-pods(R). The team's research paper, "Nitric Oxide-Releasing Microparticles as a Potent Antimicrobial Therapeutic Against Chronic Rhinosinusitis Bacterial Isolates," won the 2018 American Rhinologic Society's Best Basic Science Manuscript Award and was presented at the organization's national meeting. [Read Article] 

• Jonas Salk Award from City University of NY: The Salk Scholarship recognizes the high ability and scholarship of those who plan careers in medicine and the biological sciences and who are judged likely to make significant contributions to medicine and research; they are selected on the basis of original research papers undertaken with prominent scientist mentors

• Elected a Fellow of the American Physical Society

• Member of the selection committee of the Albany Prize in Medicine and Biomedical Research

• Distinguished member of technical staff at AT&T Bell Labs

• Young Men’s Division Chair in Cardiovascular Physiology

Adam Friedman, M.D., FAAD, Co-Scientific Founder of Zylö

• The Journal of Drugs in Dermatology [JDD] awarded Adam Friedman MD FAAD with the Innovations in Residency Training Award at the recent Orlando Dermatology Aesthetic & Clinical Conference [ODAC] held in Miami.  The award recognizes individuals that foster innovation and improvement in their residency programs, that increase emphasis on educational outcomes, and that serve as exemplary role models for dermatology residents. [Read Article] 

• Elle Beauty Genius Award, 2017

• American Academy of Dermatology Annual Meeting Poster Task Force Award, First Place, 2015

• Nanoscience Research Leaders Award, 2015

• American Dermatologic Association Young Leader Award, 2014

• Feldstein Foundation Medical Research Award, 2014

• American Academy of Dermatology Everett C. Fox, MD Award, First Place, 2009

• American Academy of Dermatology Poster 

• La Roche-Posay North American Foundation Award, First Place, 2009

• Exhibit Task Force National Poster Award, 2008

• American Society of Dermatologic Surgery Cutting Edge Research Grant Award, 2008

• American Academy of Dermatology Poster Exhibit Task Force National Poster Award, 2007

• Medical Society of the State of New York Basic Science Award, 2007

George Han, M.D., Ph.D.

• 14th Annual Julius Murmur Awardee for his work "Nitric Oxide Releasing Nanoparticles: Development, Characterization, and Application of a Novel Therapeutic"  Thesis Mentor: Dr. Joel M. Friedman